Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04793958
Title Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Mirati Therapeutics Inc.
Indications

colorectal carcinoma

Therapies

Adagrasib + Cetuximab

Fluorouracil + Leucovorin + Oxaliplatin

Fluorouracil + Irinotecan + Leucovorin

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.